Clinical Trial Update: Metabolomic Variations in the Saxagliptin-Treated Type 2 Diabetes Mellitus Patients [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update investigates metabolomic variations in patients with Type 2 diabetes mellitus treated with saxagliptin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Saxagliptin (saxagliptin)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Type 2 Diabetes | Phase 4 | Status: UNKNOWN